HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taisho's Strong Showing In Japan Offsets Lower Sales In Europe

Executive Summary

Japan's Taisho reported higher sales in the six months ended 30 September as the continued recovery of the domestic OTC market offset a weaker performance overseas.

You may also be interested in...



With Investor Support Thin On The Ground, Unilever Won't Up Bid For GSK Consumer Healthcare

Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.

Alliance Pharma Eyes OTC Acquisitions Following Strong 2021

UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.

France Adds 12 OTCs To Free Access List

France's medicines regulator ANSM has added 12 OTCs to its "free access" list of products available for self-selection by consumers in pharmacies.

Topics

UsernamePublicRestriction

Register

RS151962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel